Navigation Links
Flagship Biosciences and Corritori Consulting Announce Strategic Alliance - Companies Now Delivering Regulatory Services to the Pharmaceutical Industry
Date:5/1/2020

Flagship Biosciences, providers of expert tissue data insights, today announced an alliance with Corritori Consulting Inc., a biopharmaceutical and regulatory services advisor. The companies now deliver regulatory strategy and support to clients in the pharmaceutical and companion diagnostics industries. Flagship and Corritori are taking a collaborative approach to empower more confident and informed regulatory decisions through every phase of the drug development life cycle, for faster development and improved patient care and response.

Navigating the complex world of drug and companion diagnostic development can be a challenge. Flagship and Corritori Consulting will help clients at every step of the development process, from early discovery through commercialization, to prepare for review and approval by the FDA as well as ex-US agencies. The alliance builds on pharmaceutical market integration trends as companies attempt to adapt and scale with seamless internal and external collaborations.

“This alliance amplifies Flagship’s ability to offer regulatory and laboratory biomarker development strategies at all stages of the approval process,” said Meredith James, Flagship’s Chief Operating Officer. “Corritori Consulting’s expertise and deep understanding of regulatory standards and pathways provides concise, stepwise regulatory support in a time and cost-efficient manner. Together, Flagship and Corritori integrate seamlessly with a client’s development team through the entire development process to better ensure FDA and therapeutic success.”

“Our scientific and regulatory leadership and client success track record make Corritori Consulting uniquely suited to support the complex development required by Flagship’s clients,” said Suzana Corritori, President of Corritori Consulting. “We offer complementary services and solid experience to help clients be more efficient. With so many agency guidelines and regulations, there are many potential ways to address a challenge and we’re excited to help Flagship’s clients to find the right approach throughout the development process.”

About Flagship Biosciences
Founded in 2009 and headquartered in Westminster, Colorado, Flagship Biosciences, Inc. is a technology-driven tissue analysis services company delivering the most accurate and informative data available. It is revolutionizing tissue analysis to improve drug development and diagnostics using the power of AI with a consultative approach. Flagship’s services and technology dramatically improve on the data and interpretation from traditional pathology methods, eliminating variability and bringing new insights to tissue analysis results. With expert scientific consultation on every project, Flagship’s team interprets results, contextualizes tissue biology, and identifies the best course for success. flagshipbio.com

About Corritori Consulting Inc.
Corritori Consulting Inc. is an Orange County-based drug development consulting service firm founded in 2008 by Suzana Corritori, MD, Ph.D., MSc., whose career spans over 30 years in biopharmaceutical and medical device product development. Corritori Consulting Inc. provides comprehensive, multidimensional drug development and regulatory expertise in both the domestic and international arenas, integrating medical, clinical, nonclinical, and translational science elements for an effective and targeted regulatory product development.

###

For more information please contact Pamela Curran of Stratos Global Marketing, at pam@stratosglobalmarketing.com or +1 (303) 818 9316.

Read the full story at https://www.prweb.com/releases/flagship_biosciences_and_corritori_consulting_announce_strategic_alliance_companies_now_delivering_regulatory_services_to_the_pharmaceutical_industry/prweb17085211.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Flagship Biosciences Hires New Vice President of Clinical Diagnostics
2. Meredith James, HT, PMP, Joins Flagship Biosciences as Vice President of Operations
3. Indivumed Partners with Flagship Biosciences to Provide Global Tissue-Based Diagnostics Services
4. Synaptics Delivers Touch Controller Solutions to Googles Latest Flagship Nexus Smartphones
5. Synaptics Brings Natural ID Technology to Sharps Newest Flagship Smartphone
6. Synaptics Touchscreen and Display Driver IC Solutions Power Xiaomis Latest Flagship Smartphones
7. FPC Wins DW for 1021 Touch Sensor for Flagship Smartphone from Chinese Top 5 Smartphone OEM
8. FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM
9. Huge new influx of Graphene Flagship partners
10. Flagship US Arctic research facility welcomes EU scientists
11. INDIGO Biosciences Announces Record Revenue Numbers for 2019
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2020)... (PRWEB) , ... May 14, 2020 , ... ... job board for medical sales representatives, found the 2019 average medical sales rep ... findings risk being shadowed by uncertainties amid the COVID-19 global crisis. , The ...
(Date:5/1/2020)... ... 30, 2020 , ... Flagship Biosciences , providers of ... biopharmaceutical and regulatory services advisor. The companies now deliver regulatory strategy and support ... taking a collaborative approach to empower more confident and informed regulatory decisions through ...
(Date:4/30/2020)... , ... April 29, 2020 , ... ... positioned for continued growth – delivering innovative solutions for a wide range of ... aerospace and government agencies. A month into the new decade, it was clear ...
Breaking Biology News(10 mins):
(Date:5/30/2020)... ... May 29, 2020 , ... The Conference Forum ... newsletter solely dedicated to the unique role of the Chief Medical Officer in ... the responsibilities, problem-solving, best practices and career development of CMOs and Heads of ...
(Date:5/21/2020)... , ... May 21, 2020 , ... ... clinical trials will cause long-term harm , Contrary to conventional wisdom that says ... study finds many companies will emerge from the pandemic commercially weaker, dealing ...
(Date:5/15/2020)... ... May 14, 2020 , ... ... (hMSC) working cell banks and hMSC bioprocess systems, today announced the launch ... of hMSC-derived extracellular vesicles (EVs). RoosterCollect™-EV-CC is the only system designed with ...
(Date:5/14/2020)... ... May 12, 2020 , ... DuPont Nutrition ... distribution partner for all personal care ingredients in Russia and Belarus. Beginning May ... preservative portfolio for personal care. , The GENENCARE®OSMS product line contains ...
Breaking Biology Technology: